Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ib Trial of COmbined 5'aZacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain and Solid Tumors

NCT03206021 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT03206021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ib Trial of COmbined 5'aZacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain and Solid Tumors
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2017
Completion date
March 1, 2024
Enrollment
31 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

childhood solid tumor, ependymoma, recurrent childhood, recurrent childhood cns tumor